October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.
As of ...
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.
As of ...
October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage ...
September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 26, 2014 — The American Association for Thoracic Surgery (AATS) has released new evidence-based guidelines for ...
September 26, 2014 — AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible ...
September 15, 2014 — A new gene-directed drug being tested through a research study called GENETIC-AF may improve care ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein ...
September 2, 2014 – John Muir Health's Concord medical center is the first hospital in Northern California and one of ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for ...
August 18, 2014 — A clinical trial being conducted at Mission Health using Medtronic's Phased Radiofrequency (RF) ...
August 14, 2014 — New data from the Medtronic Inc. Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
July 30, 2014 — St. Jude Medical announced CE mark approval and first use of the FlexAbility ablation catheter, a novel ...
Paul Keall, Ph.D., FAAP, professor and NHMRC Australian Fellow at Radiation Physics Laboratory at the University of ...
July 16, 14 — A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting ...